These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 39302072)
1. Diagnostic and Therapeutic Implications of a FUS::TFCP2 Fusion and ALK Activation in a Metastatic Rhabdomyosarcoma. Csizmok V; Grisdale CJ; Williamson LM; Lim HJ; Lee L; Renouf DJ; Jones SJM; Marra MA; Laskin J; Smrke A Genes Chromosomes Cancer; 2024 Sep; 63(9):e23259. PubMed ID: 39302072 [TBL] [Abstract][Full Text] [Related]
2. Head and neck rhabdomyosarcoma with TFCP2 fusions and ALK overexpression: a clinicopathological and molecular analysis of 11 cases. Xu B; Suurmeijer AJH; Agaram NP; Zhang L; Antonescu CR Histopathology; 2021 Sep; 79(3):347-357. PubMed ID: 33382123 [TBL] [Abstract][Full Text] [Related]
3. Rhabdomyosarcoma With Zhong P; Wei S; Xiao H; Zeng Y Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350 [TBL] [Abstract][Full Text] [Related]
4. A subset of epithelioid and spindle cell rhabdomyosarcomas is associated with TFCP2 fusions and common ALK upregulation. Le Loarer F; Cleven AHG; Bouvier C; Castex MP; Romagosa C; Moreau A; Salas S; Bonhomme B; Gomez-Brouchet A; Laurent C; Le Guellec S; Audard V; Giraud A; Ramos-Oliver I; Cleton-Jansen AM; Savci-Heijink DC; Kroon HM; Baud J; Pissaloux D; Pierron G; Sherwood A; Coindre JM; Bovée JVMG; Larousserie F; Tirode F Mod Pathol; 2020 Mar; 33(3):404-419. PubMed ID: 31383960 [TBL] [Abstract][Full Text] [Related]
5. Spindle cell rhabdomyosarcoma of bone with FUS-TFCP2 fusion: confirmation of a very recently described rhabdomyosarcoma subtype. Dashti NK; Wehrs RN; Thomas BC; Nair A; Davila J; Buckner JC; Martinez AP; Sukov WR; Halling KC; Howe BM; Folpe AL Histopathology; 2018 Sep; 73(3):514-520. PubMed ID: 29758589 [TBL] [Abstract][Full Text] [Related]
6. Expanding the Spectrum of Intraosseous Rhabdomyosarcoma: Correlation Between 2 Distinct Gene Fusions and Phenotype. Agaram NP; Zhang L; Sung YS; Cavalcanti MS; Torrence D; Wexler L; Francis G; Sommerville S; Swanson D; Dickson BC; Suurmeijer AJH; Williamson R; Antonescu CR Am J Surg Pathol; 2019 May; 43(5):695-702. PubMed ID: 30720533 [TBL] [Abstract][Full Text] [Related]
7. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases. Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562 [TBL] [Abstract][Full Text] [Related]
8. [Clinicopathological study of epithelioid and spindle cell rhabdomysarcoma with EWSR1/FUS-TFCP2 fusion]. Li HL; Mo CH; Xie L; Wu YX; Zeng M; Mao RJ Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):58-63. PubMed ID: 38178748 [No Abstract] [Full Text] [Related]
9. Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with Valério E; Furtado Costa JL; Perez Fraile NM; Credidio CH; Taveira Garcia MR; Neto CS; Costa FD Int J Surg Pathol; 2023 Aug; 31(5):861-865. PubMed ID: 36474403 [TBL] [Abstract][Full Text] [Related]
10. Rhabdomyosarcoma With Ishiyama T; Kato I; Ito J; Matsumura M; Saito K; Kawabata Y; Kato S; Takeyama M; Fujii S Int J Surg Pathol; 2023 Aug; 31(5):805-812. PubMed ID: 36437645 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of rhabdomyosarcoma with novel FET::TFCP2 and TIMP3::ALK fusion: report of two cases and literature review. Duan FL; Yang H; Gong X; Zuo Z; Qin S; Ji J; Zhou C; Dai J; Guo P; Liu Y Histopathology; 2023 Feb; 82(3):478-484. PubMed ID: 36350070 [TBL] [Abstract][Full Text] [Related]
12. Spindle cell rhabdomyosarcomas: With TFCP2 rearrangements, and novel EWSR1::ZBTB41 and PLOD2::RBM6 gene fusions. A study of five cases and review of the literature. Bradová M; Mosaieby E; Michal M; Vaněček T; Ing SK; Grossmann P; Koshyk O; Kinkor Z; Laciok Š; Nemcová A; Straka Ľ; Farkas M; Michal M; Švajdler M Histopathology; 2024 Apr; 84(5):776-793. PubMed ID: 38114270 [TBL] [Abstract][Full Text] [Related]
13. Spindle cell rhabdomyosarcoma in a lumbar vertebra with FUS-TFCP2 fusion. Tagami Y; Sugita S; Kubo T; Iesato N; Emori M; Takada K; Tsujiwaki M; Segawa K; Sugawara T; Kikuchi T; Hasegawa T Pathol Res Pract; 2019 Aug; 215(8):152399. PubMed ID: 30948206 [TBL] [Abstract][Full Text] [Related]
14. Bone and soft tissue tumors: clinicoradiologic-pathologic molecular-genetic correlation of novel fusion spindled, targetable-ovoid, giant-cell-rich, and round cell sarcomas. Fanburg-Smith JC; Smith JD; Flemming DJ Skeletal Radiol; 2023 Mar; 52(3):517-540. PubMed ID: 36542130 [TBL] [Abstract][Full Text] [Related]
15. Pediatric spindle cell/sclerosing rhabdomyosarcoma with Fang Z; Duan C; Wang S; Fu L; Yang P; Yu T; Deel MD; Lau LMS; Ma X; Ni X; Su Y Transl Pediatr; 2024 Jan; 13(1):178-191. PubMed ID: 38323177 [TBL] [Abstract][Full Text] [Related]
16. Complete mimicry: Rhabdomyosarcoma with FUS::TFCP2 fusion masquerading as carcinoma-diagnostic challenge and report of two cases. Carrillo-Ng H; Liang Y; Chang S; Afkhami M; Gernon T; Bell D; Arias-Stella JA Genes Chromosomes Cancer; 2023 Jul; 62(7):430-436. PubMed ID: 37057803 [TBL] [Abstract][Full Text] [Related]
17. The combination of radiotherapy and ALK inhibitors is effective in the treatment of intraosseous rhabdomyosarcoma with FUS-TFCP2 fusion transcript. Brunac AC; Laprie A; Castex MP; Laurent C; Le Loarer F; Karanian M; Le Guellec S; Guillemot D; Pierron G; Gomez-Brouchet A Pediatr Blood Cancer; 2020 May; 67(5):e28185. PubMed ID: 31965718 [No Abstract] [Full Text] [Related]
18. FET(EWSR1)-TFCP2 Rhabdomyosarcoma: An Additional Example of this Aggressive Variant with Predilection for the Gnathic Bones. Koutlas IG; Olson DR; Rawwas J Head Neck Pathol; 2021 Mar; 15(1):374-380. PubMed ID: 32504289 [TBL] [Abstract][Full Text] [Related]
19. Cutaneous rhabdomyosarcoma with FUS::TFCP2 fusion: A case report emphasizing early detection. Demirkesen C; Danyeli AE; Yıldız P; Ertekin SS; Yılmaz B; Karahan Sİ; Bahrami A J Cutan Pathol; 2023 Dec; 50(12):1059-1064. PubMed ID: 37669767 [TBL] [Abstract][Full Text] [Related]
20. Rhabdomyosarcoma with TFCP2 Rearrangement or Typical Co-expression of AE1/AE3 and ALK: Report of Three New Cases in the Head and Neck Region and Literature Review. Gallagher KPD; Roza ALOC; Tager EMJR; Mariz BALA; Soares CD; Rocha AC; Abrahão AC; Romañach MJ; Carlos R; Hunter KD; Lopes MA; Vargas PA; Santos-Silva AR Head Neck Pathol; 2023 Jun; 17(2):546-561. PubMed ID: 36374445 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]